Management ChangeMar 30, 2026, 03:23 AM
Eli Lilly Appoints Carolyn Bertozzi to Board of Directors
AI Summary
Eli Lilly has appointed Carolyn R. Bertozzi, a Stanford University professor and Howard Hughes Medical Institute Investigator, to its Board of Directors, effective December 8, 2025. Dr. Bertozzi will serve on the Science and Technology Committee and the Ethics and Compliance Committee, bringing expertise in chemistry and systems biology, which could influence Lilly's strategic direction and innovation efforts.
Key Highlights
- Carolyn R. Bertozzi elected to Eli Lilly's Board of Directors, effective December 8, 2025.
- Dr. Bertozzi is a professor at Stanford University and an Investigator at the Howard Hughes Medical Institute.
- She will serve on the Board's Science and Technology Committee and the Ethics and Compliance Committee.
Price Impact
More from LLY